« Back
Home /
GLPG0187

GLPG0187

Item no.	M5241-1mg
Manufacturer	AbMole
CASRN	1320346-97-1
Amount	1mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Breast Cancer
Type	Inhibitors
Specific against	other
Purity	>98.5%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Target Information	Integrin
Molecular Weight	595, 71
Solubility	10mM in DMSO
Bioactivity information	GLPG0187 inhibited the progression of bone metastasis. Maximum efficacy of inhibition of bone metastasis was achieved when GLPG0187 was combined with the standard-of-care metastatic breast cancer treatments.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M5241-1mg-safety-datasheet.pdf